# US 2012/0252698 A1 · Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252698 A1
- Document ID: US20120252698A1
- Status: Published application
- Kind: A1
- Application number: 13/496,574
- Filed: 2010-09-16
- Published: 2012-10-04
- Earliest claimed: 2009-09-16
- Inventors: David Gruber; Hung-Teh Kao; Vincent Pieribone
- Web page: https://patentgrep.com/patent/US20120252698A1

## CPC

- C07K 14/43504: {from invertebrates}
- C12Q 1/485: {involving kinase}
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- G01N 2333/43504: from invertebrates
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention concerns novel isolated fluorescent proteins, variants thereof, and polynucleotides encoding the same. Methods for making and using the polypeptides and polynucleotides are also provided. For example, methods to detect protein-protein interactions, to develop novel fluorescent reagents, to monitor cellular events, as well as cell-based methods for screening for kinase or phosphatase inhibitors, are set forth. Kits to carry out the methods of the invention are also taught.

## Claims

### Claim 1

An isolated fluorescent polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44.

### Claim 2

An isolated fluorescent polypeptide variant, wherein the fluorescent polypeptide variant comprises at least 85% sequence identity to SEQ ID NO: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.

### Claim 3

An isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NOS: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.

### Claim 4

An isolated polynucleotide encoding a fluorescent polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44, wherein the isolated polynucleotide does not have a nucleotide sequence set forth in any of SEQ ID NOS: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.

### Claim 5

An isolated polynucleotide comprising a polynucleotide sequence having at least 85% sequence identity to SEQ ID NOS: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 or 45.

### Claim 6

An isolated polynucleotide encoding a fluorescent polypeptide variant, wherein the fluorescent polypeptide variant comprises at least 85% sequence identity to SEQ ID NO: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44, wherein the isolated polynucleotide does not have a polynucleotide sequence having at least 85% sequence identity to any of SEQ ID NOS: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.

### Claim 7

A fusion protein comprising an amino acid sequence of a protein of interest operatively joined to an amino acid sequence selected from the group consisting of SEQ ID NOS: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44.

### Claim 8

A fusion protein comprising an amino acid sequence of a protein of interest operatively joined to an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.

### Claim 9

A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence selected from the group consisting of SEQ ID NOS: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.

### Claim 10

A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44, wherein the nucleotide sequence encoding the polypeptide does not have a nucleotide sequence set forth in any of SEQ ID NOS: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.

### Claim 11

A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence encoding a fluorescent polypeptide variant, wherein the fluorescent polypeptide variant has at least 85% sequence identity to SEQ ID NO: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.

### Claim 12

A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence encoding a fluorescent polypeptide variant, wherein the fluorescent polypeptide variant comprises at least 85% sequence identity to SEQ ID NO: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44, wherein the nucleotide sequence encoding the fluorescent polypeptide variant does not have a nucleotide sequence having at least 85% sequence identity to any of SEQ ID NOS: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.

### Claim 13 (depends on 1, 2)

A kit for the detection of protein-protein interactions, comprising the isolated fluorescent polypeptide or variant thereof of claim 1 or 2.

### Claim 14 (depends on 3, 6)

A kit comprising an isolated polynucleotide of claim 3 or 6.

### Claim 15 (depends on 1, 2)

A FRET pair comprising at least one isolated fluorescent protein of claim 1 or 2.

### Claim 16

A method of screening for a compound that alters the activity of a protein kinase or phosphatase, comprising
providing a cell which expresses said protein kinase or phosphatase and a fluorescent protein, wherein at least one fluorescent characteristic of said fluorescent protein changes upon phosphorylation by said kinase or dephosphorylation by said phosphatase;
subjecting said cell to a candidate compound;
detecting said fluorescent characteristic under conditions that permit phosphorylation of said fluorescent protein by said kinase or dephosphorylation by said phosphatase, and
correlating the fluorescent characteristic detected with a determination that said candidate compound alters the activity of said protein kinase or phosphatase.

### Claim 17 (depends on 16)

The method of claim 16, wherein the characteristics are selected from the group consisting of fluorescence intensity, the shape of excitation spectra, the shape of emisson spectra, fluorescence lifetime, multiphoton cross-section, fluorescence resonance energy transfer efficiency, and bioluminescence resonance energy transfer efficiency.

### Claim 18 (depends on 16)

The method of claim 16, wherein said protein kinase is selected from the group consisting of Akt1, Akt2, Akt3, VEGF, Src, MET, KIT, ERBB2, FAK, PKA, PKC, a mitogen-activated protein kinase, TrkB, Fyn, and cdc2.

### Claim 19 (depends on 18)

The method of claim 18, wherein the mitogen-activated protein kinase is selected from the group consisting of ERK1, ERK2, MAPK4, MAPK6, MAPK7, MAPK8, MAPK9, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, and MAPK15.

### Claim 20 (depends on 16)

The method of claim 16, wherein said protein kinase is Akt1.

### Claim 21 (depends on 16)

The method of claim 16, wherein said fluorescent protein is the PhosFluor protein comprising the amino acid sequence of SEQ ID NO: 10 or a variant thereof.

### Claim 22 (depends on 21)

The method of claim 21, wherein said variant is a modified PhosFluor protein comprising at least one consensus sequence for phosphorylation by said protein kinase.

### Claim 23 (depends on 22)

The method of claim 22, wherein said protein kinase is Akt1.

### Claim 24 (depends on 22)

The method of claim 22, wherein said modified PhosFluor protein is obtained by (a) replacing one or more phosphorylation sites in the native PhosFluor protein with a consensus sequence for phosphorylation by Akt1; (b) inserting at least one consensus sequence for phosphorylation by Akt1 into the native PhosFluor protein; or a combination of (a) and (b).

### Claim 25 (depends on 16)

The method of claim 16, wherein said cell is a bacterial cell, a fungal cell, a plant cell, an avian cell, or a mammalian cell.

### Claim 26 (depends on 16)

The method of claim 16, wherein said cell is a mammalian cell.

### Claim 27 (depends on 16)

The method of claim 16, wherein said fluorescent characteristic is fluorescence intensity, emission spectrum, or excitation spectrum.

### Claim 28 (depends on 16)

The method of claim 16, wherein said change in at least one fluorescent characteristic comprises an increase in fluorescence intensity.

### Claim 29 (depends on 28)

The method of claim 28, wherein a reduced increase in intensity indicates that said candidate compound inhibits the activity of said kinase or phosphatase.

### Claim 30 (depends on 16)

The method of claim 16, wherein the method is performed in a multi-well array format, and said candidate compound is provided by a combinatorial library of compounds.

### Claim 31 (depends on 16)

The method of claim 16, wherein said protein kinase or phosphatase and said fluorescent protein are independently expressed from an expression vector or vectors.

### Claim 32 (depends on 16)

The method of claim 16, wherein the fluorescent protein is a fusion protein comprising an amino acid sequence of a protein of interest operatively joined to an amino acid sequence selected from the group consisting of SEQ ID NOS: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44.

### Claim 33 (depends on 16)

The method of claim 16, wherein the fluorescent protein is a fusion protein comprising an amino acid sequence of a protein of interest operatively joined to an amino acid sequence comprising at least 85% sequence identity to SEQ ID NO: 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.

### Claim 34 (depends on 33)

The method of claim 33, wherein said fluorescent protein is the PhosFluor protein comprising the amino acid sequence of SEQ ID NO: 10 or a variant thereof.

### Claim 35

An isolated modified PhosFluor protein comprising at least one heterologous consensus sequence for phosphorylation by a protein kinase inserted into the amino acid sequence of SEQ ID NO: 10.

### Claim 36 (depends on 35)

An isolated nucleic acid encoding the modified PhosFluor protein of claim 35.

### Claim 37 (depends on 36)

An expression vector comprising the nucleic acid of claim 36.

### Claim 38 (depends on 36)

A host cell comprising the expression vector of claim 36.

### Claim 39 (depends on 38)

The host cell of claim 38, further comprising a vector which encodes and is capable of expressing said protein kinase.
